FTI
BIIB icon

Fiduciary Trust International’s Biogen BIIB Stock Holding History

Fiduciary Trust International’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-410
Closed -$123K – 157
2018
Q4 		$123K Buy
+410
New +$131K 0.04% 130
2013
Q4 		– Sell
-964
Closed -$232K – 131
2013
Q3 		$232K Buy
+964
New +$216K 0.08% 120

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fiduciary Trust International's BIIB Position: Q1 2019 in Review

Fiduciary Trust International sold out of Biogen (BIIB) in Q1 2019, closing a stake of 410 shares — an estimated $123K sold.

Fiduciary Trust International first reported a position in BIIB in Q3 2013 and held it in 2 quarters. The position peaked at $232K in Q3 2013. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Fiduciary Trust International reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Fiduciary Trust International sold 410 Biogen shares in Q1 2019, an estimated $123K.
  • Fiduciary Trust International first reported a position in Biogen in Q3 2013 and held it in 2 quarters.
  • Fiduciary Trust International's Biogen position peaked at $232K in Q3 2013.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Fiduciary Trust International's 13F filing for Q1 2019, filed 7 May 2019.